Product Liability vs Recall vs Clinical Trial Insurance

CALL FOR EXPERT ADVICE
GET A QUOTE

Confused about which policy covers what? Here’s a clear, practical comparison of Product Liability, Product Recall/Withdrawal and Clinical Trial insurance — and how pharmaceutical manufacturers and life-sciences businesses can structure them together.

CALL FOR EXPERT ADVICE
GET A QUOTE

We compare quotes from leading insurers

  • Allianz
  • Aviva
  • QBE
  • RSA
  • Zurich
  • NIG

INSURANCE CLARITY THAT HELPS YOU TAKE OFF

Three Policies. Three Different Problems.

Pharmaceutical and life-sciences businesses often talk about “liability insurance” as if it’s one thing. In reality, the industry typically relies on different policies to cover different loss pathways. Product Liability is mainly about third-party injury or damage caused by products after supply. Product Recall/Withdrawal is about the operational cost of removing product from the market (even if nobody is injured). Clinical Trial insurance is designed to protect sponsors and others involved in clinical studies if trial participants are injured or allege harm related to the investigational product or trial procedures.

Confusion between these covers is one of the most common causes of uninsured losses. A business may buy product liability and assume it includes recall costs. Or a business may begin clinical activity and assume product liability automatically covers investigational trials. The result can be gaps at the worst possible time: when regulators, customers or trial sites require immediate response.

This page explains what each policy is designed to do, what it typically covers, where exclusions or limitations commonly apply, and how manufacturers and CDMOs can structure an integrated programme.

At-a-Glance Comparison

Think of the three covers like this:

  • Product Liability = “Someone claims the product caused harm.”
  • Product Recall/Withdrawal = “We must remove product from supply and manage the logistics.”
  • Clinical Trial insurance = “A trial participant alleges harm connected to a study.”

The same incident can touch more than one policy. For example, a contamination event might lead to a withdrawal (recall costs), and later a patient claim (product liability). Or an issue with an investigational product might lead to trial participant allegations (clinical trial), plus reputational and logistics costs that fall outside standard liability.

Product Liability Insurance

Product liability insurance is designed to protect your business if a third party alleges that a product you manufactured or supplied caused bodily injury, illness, death, or property damage. For pharmaceutical manufacturers, this can involve complex causation, large legal costs, and high severity exposures — especially for products supplied internationally.

Product liability is typically triggered by a claim (or potential claim) from a third party. It commonly covers legal defence costs, settlement costs and damages where you are legally liable. It may also include “completed operations” depending on policy structure, and it may interact with contractual indemnities within supply agreements.

Product liability is essential — but it is not designed to pay for the internal operational cost of removing product from the supply chain. That’s the job of recall/withdrawal cover.

Typical Product Liability Coverage


  • Third-party bodily injury/illness (including legal defence)
  • Third-party property damage (including legal defence)
  • Court and expert witness costs
  • Worldwide coverage options (territorial and jurisdictional limits apply)

Underwriting focus often includes product types, territories (EU/US), batch values, distribution model, quality controls, complaint history and any prior recalls.

Common Misunderstandings


  • Assuming recall/withdrawal costs are automatically covered
  • Assuming contractual penalties are covered (often not)
  • Not checking USA/Canada coverage and jurisdiction wording
  • Not disclosing sterile products or high-risk routes of administration

Product liability is powerful when the scenario is “harm claim”. If the scenario is “quality issue with no injury”, product liability may not pay the costs you care about most.

Product Recall / Withdrawal Insurance

Recall (or withdrawal) insurance is designed to cover the operational and logistical costs of removing product from the supply chain when there is a known or suspected defect, contamination, mislabelling, or other quality issue that makes the product unsafe, non-compliant or unfit for intended use. This can be required even when no one has been harmed.

In pharmaceuticals, withdrawals can arise from deviations, stability concerns, packaging errors, data integrity issues, or GMP findings that undermine confidence in product release. The cost is often dominated by logistics: identifying affected batches, contacting customers, arranging returns, managing quarantine, disposal/destruction, and documenting the process.

Importantly, recall/withdrawal is a “first-party cost” cover: it is about the cost you incur to act responsibly and protect patients, customers, and licences.

Typical Recall/Withdrawal Costs Covered


  • Notification and customer communications (wording dependent)
  • Product retrieval, transport and returns handling
  • Quarantine, storage and disposal/destruction costs
  • Replacement or refund costs (if included by policy)
  • Crisis support services (where included)

Cover triggers and sub-limits vary. Some policies require regulatory order; others respond to voluntary withdrawals when there is credible risk.

Common Limitations to Watch


  • Definition of “defect” or “contamination” can be narrow
  • Exclusions for known issues, prior deviations, or poor QC
  • Territory and batch traceability requirements
  • Contractual penalties and loss of future profit often excluded

The right structure depends on your distribution model and how quickly you could locate and retrieve affected batches.

Clinical Trial Insurance

Clinical trial insurance is designed to cover liabilities arising from clinical research — typically relating to injury to trial participants or allegations of harm connected to the investigational medicinal product (IMP) or trial procedures. It is commonly required by trial sites, ethics committees, CROs, and sponsors, and may be needed even for early-stage trials with small participant numbers.

For manufacturers and life-sciences companies, the clinical trial exposure can arise when you act as sponsor, co-sponsor, manufacturer of an IMP, or where you have contractual responsibility connected to trial supply. Policies are usually structured to reflect study protocol, territories, phases (I–IV), and who is covered (sponsor, investigators, sites).

Clinical trial cover is not a “recall” policy — it does not typically pay for the cost of withdrawing product from general commercial markets — and it is not always interchangeable with product liability. It is a specialist liability product aligned to the specific risk environment of clinical research.

Typical Clinical Trial Coverage


  • Trial participant injury claims and associated damages
  • Legal defence costs
  • Cover for sponsors and (where specified) investigators/sites
  • Protocol-based underwriting (phase, territory, participant numbers)

Requirements vary by country and trial design. Policies are usually arranged for a specific trial or a portfolio programme, depending on your pipeline.

Where Businesses Get Caught Out


  • Assuming product liability automatically covers trial participants
  • Not aligning insured parties with sponsor/investigator obligations
  • Inadequate territorial scope for multi-country trials
  • Not updating cover when protocol or phase changes

If your company is moving from development to clinical activity, it’s worth reviewing insurance early — clinical trial requirements can be time-sensitive in study start-up.

How to Structure the Three Covers Together

Many life-sciences businesses need more than one of these policies at the same time. A CDMO might need product liability for commercial supply, recall/withdrawal for first-party logistics, and clinical trial cover for investigational batches if they participate in IMP manufacturing or sponsor activity.

The goal is to avoid overlaps and gaps. Overlaps can create disputes about which insurer pays. Gaps create uninsured costs. The best approach is to map activities and allocate them cleanly: commercial product supply vs investigational trial supply vs operational withdrawal costs.

When You Typically Need Each Policy


  • Product Liability: commercial product supplied to customers/patients
  • Recall/Withdrawal: cost of retrieving/disposing product due to defect risk
  • Clinical Trial: trial participants and protocol-driven exposures

If you manufacture both commercial and investigational product on the same site, ensure the business description and policy schedules reflect both activities accurately.

Key Alignment Points to Review


  • Territories and jurisdiction (UK/EU/US, worldwide)
  • Definitions of “product”, “defect”, “clinical trial” and “insured” parties
  • Contractual indemnities and who bears recall costs
  • Claims-made vs occurrence wording differences (policy dependent)
  • How defence costs are treated (inside vs outside limits)

These details are where disputes occur. Getting them right at placement stage is far easier than arguing after an incident.

Quote icon

“We assumed product liability covered recall and trial exposures — it didn’t. Aligning the three policies gave us clarity and confidence under contract and regulator pressure.”

Commercial Director, Life Sciences Business

FREQUENTLY ASKED QUESTIONS

+-

Does product liability insurance cover product recall costs?

Not always. Product liability is mainly designed for third-party injury/illness claims and legal defence. Recall/withdrawal costs (retrieval, returns handling, disposal and notifications) are typically covered under a dedicated Product Recall/Withdrawal policy or section, often with specific triggers and sub-limits.

+-

When do I need clinical trial insurance?

You typically need clinical trial insurance when you sponsor (or co-sponsor) a clinical study, or where trial sites/ethics committees require evidence of cover for participant injury. Requirements depend on the study protocol, phase, territories, and who is responsible under trial agreements.

+-

Can a CDMO need all three covers at the same time?

Yes. CDMOs often need product liability for commercial supply, recall/withdrawal for first-party logistics costs, and clinical trial cover if they manufacture or have contractual responsibilities connected to investigational medicinal products (IMPs) and clinical studies.

+-

Is clinical trial insurance the same as product liability?

No. Clinical trial insurance is a specialist liability product designed around research protocols and participant injury exposures. Product liability typically applies to products supplied commercially. While there can be overlap in some situations, you should not assume one policy automatically covers the other without checking wording and insured activities.

+-

What limits are typical for product liability, recall and clinical trial cover?

Limits vary widely based on product risk, territories (especially US exposure), contracts and trial design. Product liability limits are often driven by distribution and severity scenarios, recall limits by batch values and retrieval complexity, and clinical trial limits by protocol requirements and participant numbers. We can help align limits to contracts and plausible worst-case scenarios.

+-

How do I get a quote for the right mix of these covers?

Call 0330 127 2333 or request a quote online. We’ll confirm your commercial products, recall exposure, trial activities (if any), territories, contracts and required limits, then approach suitable insurers and structure the programme to avoid gaps between policies.

Related Blogs